AusperBio Therapeutics Completes $37 Million Series A Financing Round
| | |

AusperBio Therapeutics Completes $37 Million Series A Financing Round

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (AusperBio) is a clinicalstage biotechnology company dedicated to advancing targeted oligonucleotide therapies. The company aims to achieve a functional cure for chronic hepatitis B (CHB) infection. The recently completed $37 million Series A financing round will support the clinical development of AusperBios lead product candidate, AHB137. Additionally,…

MorphoSys AG Announces Intention to Delist American Depositary Shares from Nasdaq
| |

MorphoSys AG Announces Intention to Delist American Depositary Shares from Nasdaq

MorphoSys AG, a global biopharmaceutical company headquartered in Planegg, Germany, has formally notified the Nasdaq Stock Market of its intention to voluntarily delist its American Depositary Shares (“ADSs”) from the Nasdaq Global Market and to deregister the ADSs under Section 12(b) of the Securities Exchange Act of 1934. The decision to delist the ADSs is…

Merck Completes Acquisition of EyeBio for the Development of Restoret™
| | |

Merck Completes Acquisition of EyeBio for the Development of Restoret™

Merck, also known as MSD, has successfully completed the acquisition of EyeBio, a leading biotech company. The acquisition adds EyeBios promising candidate, Restoret™ (EYE103), to Mercks latestage pipeline for the treatment of retinal diseases. Restoret is an investigational tetravalent, trispecific antibody designed to target the Wnt signaling pathway, with positive results from the Phase 1b/2a…

Nordic Capital Acquires Majority Stake in Sensio
| | |

Nordic Capital Acquires Majority Stake in Sensio

Nordic Capital has acquired a majority share in Sensio, a leading provider of technology for social care, with a focus on smart monitoring technology for elderly and social care settings in the Nordics. The investment aims to accelerate Sensios growth, international expansion, and enhance its technology platform and products. The companys flagship offerings include the…

Spotlight Medical Raises €6.2 Million Seed Funding Round led by Kurma Partners and Heal Capital
| | | |

Spotlight Medical Raises €6.2 Million Seed Funding Round led by Kurma Partners and Heal Capital

Spotlight Medical, a precision medicine company founded in 2024, has secured €6.2 million in a seed funding round to support the development of AIdriven prognosis tests for cancer patients. This funding will enable Spotlight Medical to bring its first prognosis test to the clinic, furthering its mission to provide personalized and effective care for cancer…

Regard Secures $61 Million Series B Funding to Expand AIPowered Clinical Insights Platform
| | |

Regard Secures $61 Million Series B Funding to Expand AIPowered Clinical Insights Platform

Regard, the AIpowered clinical insights platform, has secured a $61 million Series B funding round. The funding will support the rapid expansion of Regards platform, empowering clinicians to unlock the full potential of patient data. Oak HC/FT led the funding round, with participation from CedarsSinai Health Ventures, as well as existing investors TenOneTen Ventures, Calibrate…

Valenz Health Acquires Healthcare Bluebook in a Move to Enhance Healthcare Outcomes
| |

Valenz Health Acquires Healthcare Bluebook in a Move to Enhance Healthcare Outcomes

Valenz Health, a leading platform of integrated cost containment and payment integrity solutions, has signed a definitive agreement to acquire Healthcare Bluebook, an industryleading healthcare cost and quality navigation platform. The acquisition aims to combine their complementary offerings to create an integrated member engagement and digital front door experience. Valenz Health will leverage Healthcare Bluebooks…

ProofPilot Announces Series C Funding Round Led by Sopris Capital
| |

ProofPilot Announces Series C Funding Round Led by Sopris Capital

ProofPilot, a Clinical Experience Platform (CXP) provider, has successfully closed its Series C financing round. The funding round was led by Sopris Capital, with participation from Mitsui & Co. (U.S.A.), Inc. The companys CEO, Chris Venezia, highlighted the importance of enhancing the clinical trial experience for all stakeholders, noting that existing technologies primarily focus on…

Johnson & Johnson Completes Acquisition of Yellow Jersey for NM26 Bispecific Antibody
| |

Johnson & Johnson Completes Acquisition of Yellow Jersey for NM26 Bispecific Antibody

Johnson & Johnson has successfully completed the acquisition of Yellow Jersey, a demerged subsidiary of Numab Therapeutics, securing the global rights to NM26, a novel bispecific antibody targeting inflammatory skin diseases. The allcash transaction of approximately $1.25 billion allows Johnson & Johnson to advance NM26 into Phase 2 studies for atopic dermatitis (AD), a common…

AA Medical Acquires Surgical Product Solutions to Expand Product Portfolio
| | |

AA Medical Acquires Surgical Product Solutions to Expand Product Portfolio

AA Medical, a leading supplier of refurbished medical equipment, has announced the acquisition of Surgical Product Solutions (SPS). This strategic partnership aims to enhance the accessibility and affordability of premium medical products by expanding AA Medicals product portfolio to include SPSs range of surgical consumables. The funding will be used to further solidify AA Medicals…